Skip to content
Review Open access

Neutrophil Extracellular Traps at the Asthma + COPD Interface: Mechanisms, Experimental Models, and Therapeutic Targeting

Sep 2026 · Cells · Vol 15, pp. 1769 · 1 citation · 56 references
Medicine

TL;DR

This review examines NET biology with a primary focus on animal models that reproduce overlapping asthma and COPD features, emphasizing how epithelial injury, oxidative stress, protease activity, neutrophilic inflammation, and inflammatory cytokine networks converge to promote NET formation.

Abstract

Highlights What are the main findings? Neutrophil extracellular traps (NETs) emerge as a mechanistic link between neutrophilic inflammation, oxidative stress, epithelial injury, and extracellular matrix remodeling in the context of coexisting asthma and chronic obstructive pulmonary disease (COPD) features. Methodological heterogeneity in NET detection remains a major limitation, underscoring the need for multimodal approaches that integrate NET-associated molecular markers with imaging-based evidence of NET formation. What are the implications of the main findings? Experimental models combining asthma- and COPD-like features are essential to determine whether NETs actively contribute to persistent inflammation and structural lung remodeling rather than merely reflect neutrophil activation. Therapeutic strategies targeting NET formation or persistence, particularly peptidylarginine deiminase 4 (PAD4) inhibition and deoxyribonuclease (DNase)-based approaches, warrant further mechanistic and translational investigation in the context of coexisting asthma and COPD features. Abstract Asthma and chronic obstructive pulmonary disease (COPD) are distinct chronic airway diseases with different pathophysiological mechanisms, but they may coexist and share clinical, functional, inflammatory, and structural features. The historical terminology used to describe this coexistence has shifted away from the notion of a single overlap syndrome toward a traits-based framework, emphasizing coexisting clinical, functional, inflammatory, and structural features rather than a uniform disease entity. Within this context, neutrophil extracellular traps (NETs) are emerging as a potential mechanistic link between allergic airway inflammation, cigarette smoke injury, neutrophilic activation, mucus obstruction, and tissue remodeling. Animal models combining allergen exposure with cigarette smoke, lipopolysaccharide, infection, or elastase provide useful platforms to dissect specific components of the asthma-COPD interface. This review examines NET biology with a primary focus on animal models that reproduce overlapping asthma and COPD features, emphasizing how epithelial injury, oxidative stress, protease activity, neutrophilic inflammation, and inflammatory cytokine networks converge to promote NET formation. NETs, composed of extracellular deoxyribonucleic acid (DNA), citrullinated histone H3, myeloperoxidase, neutrophil elastase, and granular proteins, may amplify mucus viscosity, epithelial damage, innate immune activation, airway remodeling, emphysema-like injury, and persistent airflow limitation. Strategies to target this axis include deoxyribonuclease I (DNase I), peptidylarginine deiminase 4 (PAD4) inhibition, neutrophil elastase and myeloperoxidase blockade, antioxidant approaches, C-X-C motif chemokine receptor 2 (CXCR2) modulation, and interleukin-17 (IL-17) inhibition. These interventions act at distinct stages of neutrophil recruitment, NET formation, NET persistence, or NET-mediated tissue injury. A rigorous interpretation of these models requires precise terminology, multiparametric NET detection, and integration of lung mechanics, histology, inflammatory profiling, and structural outcomes. Targeting NETs may help shift preclinical research from broad overlap labels toward mechanism-driven therapeutic strategies for coexisting asthma and COPD features.

Read PDF

Similar papers

Review Open access Nov 2026

The dual role of small EVs in asthma and chronic obstructive pulmonary disease: from pathogenesis to clinical translation

Asthma and chronic obstructive pulmonary disease (COPD) are leading causes of chronic respiratory morbidity, yet current therapies fail to halt airway remodeling or disease progression. Small extracellular vesicles (small EVs), a nanoscale subset of extracellular vesicles that includes exosomes, have emerged as key med...

Jun-Hua Li, Zhou-Qiang Li, Hai-Ning Hu et al. · 0 citations
Review Open access Oct 2026

Neutrophil Extracellular Traps (NETs), Immunothrombosis and the Microvascular Siege in Sepsis‐ARDS

ABSTRACT Sepsis‐associated acute respiratory distress syndrome (ARDS) remains associated with substantial mortality despite decades of research, and the reasons why many disease‐modifying treatments have failed remain incompletely understood. This narrative review synthesizes emerging evidence implicating neutrophil ex...

Amr A. El-Sehrawy, Djaloliddin Mansurov, Mirza R. Baig et al. · 0 citations
Review Open access Oct 2026

COPD: From Endothelium to New Therapies

Chronic Obstructive Pulmonary Disease (COPD) is a heterogeneous, progressive inflammatory condition of the airways and lung parenchyma, representing one of the leading causes of morbidity and mortality worldwide. Traditionally framed as a disease of airflow obstruction, COPD is now increasingly recognized as a systemic...

L. Mondini, M. Ramaccia, M. Hughes et al. · 0 citations
Review Open access Nov 2026

Bidirectional Crosstalk Between Macrophage Efferocytosis and Polarization in Asthma: Endotype-Specific Mechanisms and Therapeutic Perspectives

Abstract Despite advances in asthma treatment, some patients continue to experience persistent airway inflammation, poor treatment response, and progressive airway remodeling. One possible contributor is impaired efferocytosis, the regulated recognition and clearance of apoptotic cells by macrophages, which can hinder...

Ping Wang, Wei-Jia Li, Rui-Bing Li et al. · 0 citations
Open access Oct 2026

How Innate Immune Mechanisms Contribute to the Chronic Nature of COPD?

Background Chronic Obstructive Pulmonary Disease (COPD) is characterized by persistent inflammation, airflow limitation, and progressive tissue destruction. While smoking is a major risk factor, recent research links innate immune mechanisms, oxidative stress, and protease imbalances to disease chronicity. Objectives T...

B. M. Khashman, Yasir M. Abdulateef, H. N. Eyada · 0 citations
Review Open access Nov 2026

Airway Microbiome–Metabolite Interactions in Acute Exacerbations of Chronic Airway Diseases

Microbial communities are associated with exacerbations of asthma, chronic obstructive pulmonary disease (COPD), and bronchiectasis, but their composition alone does not explain how they influence host injury or protection. This comprehensive review integrates clinical observations and functional experiments, distingui...

Yan-Yu Chen, Wen-Pei Li, J. Tang et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.